Clinical Trial Update: Anti-platelet + Pembro for H&N Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial testing an anti-platelet agent in combination with Pembrolizumab for head and neck cancer has completed. The update reflects the complete status o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED